Literature DB >> 1645562

Differences in vascular response between primary and transplanted tumours.

S B Field1, S Needham, I A Burney, R J Maxwell, J E Coggle, J R Griffiths.   

Abstract

The vast majority of studies on tumour vasculature are performed on transplanted tumours in rodents. However, it is known that there may be differences between primary and transplanted lesions. The purpose of this study is to test whether a specific vascular response is similar in primary tumours and in transplanted tumours derived from them. The technique used was to give an intraperitoneal injection of 5 mg kg-1 hydralazine, which is known to result in hypoxia in transplanted tumours. Changes in perfusion were indicated by changes in metabolism, monitored using 31P Magnetic Resonance Spectroscopy. The primary tumours were induced by local irradiation many months previously and only 4/11 (36%) of these responded to hydralazine. One of the non responders was subsequently transplanted into isogeneic mice to produce a tumour line which was histologically very similar to the primary. Of these 16/17 (94%) responded. The difference is statistically significant (P = 0.001). The reasons for this difference are not known. A number of possibilities are discussed and in the authors' opinion, the most likely cause is that it results from an artefact of transplantation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1645562      PMCID: PMC1972409          DOI: 10.1038/bjc.1991.163

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

1.  Changes of oxygen tension in tumours induced by vasoconstrictor and vasodilator drugs.

Authors:  D B CATER; C M GRIGSON; D A WATKINSON
Journal:  Acta radiol       Date:  1962-12       Impact factor: 1.990

2.  Proceedings: Tumor angiogenesis factor.

Authors:  J Folkman
Journal:  Cancer Res       Date:  1974-08       Impact factor: 12.701

3.  Differences in growth and morphology between the spontaneous C3H mammary carcinoma in the mouse and its syngeneic transplants.

Authors:  J A McCredie; W R Inch; R M Sutherland
Journal:  Cancer       Date:  1971-03       Impact factor: 6.860

4.  The combined measurement of blood flow and metabolism in RIF-1 tumours in vivo. A study using H2 flow and 31P NMR spectroscopy.

Authors:  Z M Bhujwalla; G M Tozer; S B Field; E Proctor; A Busza; S R Williams
Journal:  NMR Biomed       Date:  1990-08       Impact factor: 4.044

5.  Reduced thermal sensitivity of the vasculature in a slowly growing tumour.

Authors:  S A Hill; K A Smith; J Denekamp
Journal:  Int J Hyperthermia       Date:  1989 May-Jun       Impact factor: 3.914

6.  Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo.

Authors:  M R Horsman; K L Christensen; J Overgaard
Journal:  Int J Hyperthermia       Date:  1989 Mar-Apr       Impact factor: 3.914

Review 7.  Determinants of tumor blood flow: a review.

Authors:  R K Jain
Journal:  Cancer Res       Date:  1988-05-15       Impact factor: 12.701

8.  Effects of hydralazine-induced vasodilation on the energy metabolism of murine tumors studied by in vivo 31P-nuclear magnetic resonance spectroscopy.

Authors:  P Okunieff; F Kallinowski; P Vaupel; L J Neuringer
Journal:  J Natl Cancer Inst       Date:  1988-07-20       Impact factor: 13.506

9.  Induction of tumour hypoxia post-irradiation: a method for increasing the sensitizing efficiency of misonidazole and RSU 1069 in vivo.

Authors:  I J Stratford; G E Adams; J Godden; N Howells
Journal:  Int J Radiat Biol       Date:  1989-03       Impact factor: 2.694

10.  The histological structure of some human lung cancers and the possible implications for radiotherapy.

Authors:  R H THOMLINSON; L H GRAY
Journal:  Br J Cancer       Date:  1955-12       Impact factor: 7.640

View more
  14 in total

Review 1.  Intravital fluorescence videomicroscopy to study tumor angiogenesis and microcirculation.

Authors:  P Vajkoczy; A Ullrich; M D Menger
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

Review 2.  Establishing the Impact of Vascular Damage on Tumor Response to High-Dose Radiation Therapy.

Authors:  Katherine D Castle; David G Kirsch
Journal:  Cancer Res       Date:  2019-08-19       Impact factor: 12.701

3.  Genetically engineered mouse models for studying radiation biology.

Authors:  Katherine D Castle; Mark Chen; Amy J Wisdom; David G Kirsch
Journal:  Transl Cancer Res       Date:  2017-07       Impact factor: 1.241

4.  Patterns of Vasculature in Mouse Models of Lung Cancer Are Dependent on Location.

Authors:  Marta Vilalta; Nicholas P Hughes; Rie Von Eyben; Amato J Giaccia; Edward E Graves
Journal:  Mol Imaging Biol       Date:  2017-04       Impact factor: 3.488

5.  Assessment of induced rat mammary tumour response to chemotherapy using the apparent diffusion coefficient of tissue water as determined by diffusion-weighted 1H-NMR spectroscopy in vivo.

Authors:  L Lemaire; F A Howe; L M Rodrigues; J R Griffiths
Journal:  MAGMA       Date:  1999-03       Impact factor: 2.310

6.  The C-neu mammary carcinoma in Oncomice; characterization and monitoring response to treatment with herceptin by magnetic resonance methods.

Authors:  L M Rodrigues; M Stubbs; S P Robinson; B Newell; J Mansi; J R Griffiths
Journal:  MAGMA       Date:  2004-12-20       Impact factor: 2.310

7.  Tumor cells, but not endothelial cells, mediate eradication of primary sarcomas by stereotactic body radiation therapy.

Authors:  Everett J Moding; Katherine D Castle; Bradford A Perez; Patrick Oh; Hooney D Min; Hannah Norris; Yan Ma; Diana M Cardona; Chang-Lung Lee; David G Kirsch
Journal:  Sci Transl Med       Date:  2015-03-11       Impact factor: 17.956

8.  Atm deletion with dual recombinase technology preferentially radiosensitizes tumor endothelium.

Authors:  Everett J Moding; Chang-Lung Lee; Katherine D Castle; Patrick Oh; Lan Mao; Shan Zha; Hooney D Min; Yan Ma; Shiva Das; David G Kirsch
Journal:  J Clin Invest       Date:  2014-07-18       Impact factor: 14.808

9.  Effects of HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) on NEU/HER2 overexpressing mammary tumours in MMTV-NEU-NT mice monitored by Magnetic Resonance Spectroscopy.

Authors:  Loreta M Rodrigues; Yuen-Li Chung; Nada M S Al Saffar; Swee Y Sharp; Laura E Jackson; Udai Banerji; Marion Stubbs; Martin O Leach; John R Griffiths; Paul Workman
Journal:  BMC Res Notes       Date:  2012-05-23

10.  The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumours.

Authors:  P K Quinn; M C Bibby; J A Cox; S M Crawford
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.